Astonea Labs Limited made its market debut on the NSE SME platform today, listing at ₹137.45 per share—1.81% above its issue price of ₹135. Despite high investor interest during the subscription period, the listing gain remained modest.
The ₹37.67 crore SME IPO consisted entirely of a fresh issue of 27.9 lakh equity shares, with no offer-for-sale (OFS) component. The public offering was open between May 27 and May 29, 2025.
The price band for the IPO was set at ₹128 to ₹135 per share, with a minimum lot size of 1,000 shares. Kfin Technologies is the registrar to the issue, and Oneview Corporate Advisors served as the sole book-running lead manager.
Astonea Labs operates in the pharmaceutical and healthcare space, and the IPO proceeds are expected to be used towards working capital requirements, expansion plans, and general corporate purposes.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash